Mahal Jeetinder Singh
SEC insider (Form 3/4/5 filer). CIK 0001882877. CEO and President at Jasper Therapeutics, Inc. (JSPR). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 6, 2026. Located in REDWOOD CITY, CA.
Companies Mahal Jeetinder Singh has filed insider reports for
- Jasper Therapeutics, Inc. (JSPR): Director, Officer, CEO and President
Mahal Jeetinder Singh
CIK: 0001882877
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Jasper Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 6, 2026JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
500K shares- - Jan 2, 2026JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
90K shares- - Jun 4, 2025JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
90K shares- - Feb 13, 2025JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
50K shares- - Dec 12, 2024JSPR
Jasper Therapeutics, Inc.
ExerciseDirect900 shares at avg. $7.10$6K - Dec 12, 2024JSPR
Jasper Therapeutics, Inc.
SaleDirect900 shares at avg. $22.11$20K - Sep 12, 2024JSPR
Jasper Therapeutics, Inc.
ExerciseDirect900 shares at avg. $7.10$6K - Sep 12, 2024JSPR
Jasper Therapeutics, Inc.
SaleDirect900 shares at avg. $21.23$19K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 6, 2026 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 500,000 | - | - | Direct |
| Jan 2, 2026 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 90,000 | - | - | Direct |
| Jun 4, 2025 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 90,000 | - | - | Direct |
| Feb 13, 2025 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Dec 12, 2024 | JSPR Jasper Therapeutics, Inc. | Exercise | 900 | $7.10 | $6,390 | Direct |
| Dec 12, 2024 | JSPR Jasper Therapeutics, Inc. | Sale | 900 | $22.11 | $19,899 | Direct |
| Sep 12, 2024 | JSPR Jasper Therapeutics, Inc. | Exercise | 900 | $7.10 | $6,390 | Direct |
| Sep 12, 2024 | JSPR Jasper Therapeutics, Inc. | Sale | 900 | $21.23 | $19,104 | Direct |
1-8 of 8 transactions